UNISOUND (09678) saw its shares rise by 10.27% in morning trading, reaching HK$322, with a turnover of HK$347 million.

CenseGroup issued a research report stating that UNISOUND's revenue is expected to accelerate over the next three years. The firm forecasts revenues of RMB1.236 billion, RMB1.923 billion, and RMB2.918 billion for 2025, 2026, and 2027, respectively, representing growth rates of 31.6%, 55.6%, and 51.7%. The company is projected to achieve profitability in 2026.

Considering the validated growth of UNISOUND's large model business and the significant potential of its AI clinical diagnosis and medical insurance cost-reduction applications, CenseGroup assigned a price-to-sales (PS) valuation of 25 times for 2026, resulting in a target price of HK$750.58. The coverage was initiated with a "Buy" rating.